Table 4 Estimation of the hazard ratio for disease-free survival
From: Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis
Study | HR estimation | Co-factors | Analysis results |
|---|---|---|---|
Fleischmann [18] | HR, 95Â % CI | Extracapsular extension, no. of positive LNs | Not significant |
Guzzo [22] | HR, 95Â % CI | Age, sex, diversion type, pT stage, adjuvant chemotherapy | Not significant |
Jensen [25] | HR, 95Â % CI | Age, sex, pT stage, pN stage, metasis above the aortic bifurcation, extracapsular extension, volume dependent LN density, diameter of largest LN, volume of metastatic LNs | Not significant |
Masson-Lecomte [28] | HR, 95Â % CI | pT stage, lymphovascular invasion, extracapsular extension, adjuvant chemoethrapy | Significant |
Mmeje [29] | P value, event no. (univariate) | - | Not significant |
Kwon [30] | HR, 95Â % CI | pT stage, pN stage, no. of positive LNs, adjuvant chemotherapy | Not significant |